Keanu Reeves is known for playing a deadly killer in the John Wick series, and his reputation helped encourage scientists to name a deadly new bacteria after him.

Researchers from the Leibniz Institute for Natural Product Research and Infection Biology discovered a new substance that can help kill fungal diseases and fungi that affect humans. The name? “Keanumycins,” which is named after Reeves.

“The lipopeptides kill so efficiently that we named them after Keanu Reeves because he, too, is extremely deadly in his roles,” researcher Sebastian Götze explained.

The scientist said Keanumycins could be used as an alternative to traditional chemical pesticides as well as to help with human ailments. According to the researchers, there are “very few drugs” available to help humans beat fungal infections, and a new product deriving from the research that went into Keanumycins could be the answer. Here’s to hoping some kind of The Last of Us-type fungal infection never becomes real and we have no need for a remedy, but you never know…

The study was recently published in the Journal of the American Chemical Society.

In other news about Keanu Reeves, the actor recently confirmed he would like to be the first human to make alien contact and that he would politely ask the aliens if they would like something to drink. Reeves also weighed in on the never-ending debate about whether or not pineapple belongs on pizza (Reeves believes it generally does not, with one exception).

John Wick: Chapter 4 is slated to hit theaters on March 24, and early box office tracking estimates suggest the movie will have the best start in franchise history.